Podcast · Learning

EuroIntervention | Editor's Choice

by EuroIntervention · English · Learning

Welcome to Editor's Choice, the new podcast by EuroIntervention where we will highlight the latest research on interventional cardiology. Our host Aaysha Cader will invite you to her conversations with the authors to explore study designs, key findings and their relevance in contemporary pratice.

New episodes: Every two weeks
Typical length: 16 min
Latest: 15 Oct 2026
Language: English

Latest episode

15 Oct 2026 · 14 minNew

Safety and Effectiveness of the Vertex Pulmonary Embolectomy System in Acute Intermediate-Risk Pulmonary Embolism: SPIRARE II Pivotal Trial

In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Catalin Toma dive into the findings of SPIRARE II. Dr Toma shares the strategy behind enriching the trial's design; core efficacy and safety endpoint results (RV/LV ratio & MAE rates); the mechanics and potential advantages of the Vertex technology; and future clinical horizons for mechanical thrombectomy. Hosted on Acast. See acast.com/privacy for more information.

Play episodeWhatsApp Download

Earlier episodes 12 most recent

S1 · E12 · 5 Oct 2026 · 16 min
Percutaneous coronary intervention using sirolimus eluting balloons in patients at high bleeding risk - The SELUTION DeNovo HBR sub-study
In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Philip Urban discuss the findings of SELUTION DeNovo HBR, comparing SEB versus DES PCI strategies. Dr Urban describes the dual-risk profile of the enrolled HBR patients and shares the hypothesis-generating results including 1-year TVF, BARC 3+ bleeding, and NACE rates which favoured the balloon arm – possibly linked to lower use of antiplatelet therapy in SEB-treated patients. Hosted on Acast. See acast.com/privacy for more information.
S1 · E11 · 24 Sep 2026 · 17 min
Phenotypes of cardiogenic shock after out-of-hospital cardiac arrest: the SCAI-V classification: Original Research
In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Nilesh Pareek discuss the SCAI-V classification for cardiogenic shock in OHCA patients. Dr Pareek explains how both haemodynamic status and lactate thresholds are incorporated into a 2x2 factorial design, describes the surprising finding of higher mortality in the systemic ischaemia group versus the haemodynamic shock group, and compares this classification with predecessors SCAI 2019 and SCAI 2022. Hosted on Acast. See acast.com/privacy for more information.
S1 · E10 · 9 Sep 2026 · 21 min
Reduced-dose direct oral anticoagulant versus antiplatelet strategies after left atrial appendage occlusion: Original Research
In this episode of Editor’s Choice, Dr Aaysha Cader and Professor Gregory Lip compare the post-LAAO clinical outcomes of low-dose DOAC, DAPT, and SAPT, based on data from the TriNetX Global Network. With limited guideline recommendations currently in place, Professor Lip summarises the findings of the comparisons; he explains why, mechanistically, reduced-dose DOAC might be preferable to antiplatelet therapy after LAAO; and shares with Dr Cader some alternative medical therapies to LAAO, which may suit certain patients better. Hosted on Acast. See acast.com/privacy for more information.
S1 · E9 · 26 Aug 2026 · 17 min
Long-Term Outcomes of High-Risk Plaques with Negative FFR: The PECTUS-obs Study
In this episode of Editor's Choice, Dr Aaysha Cader speaks with Professor Niels van Royen and Doctor Rick Volleberg about the findings of the PECTUS-obs study. They discuss the association between high-risk plaque and an approximately twofold increase in 5-year MACE; plaque rupture as a marker of both local and systemic vulnerability; and why combining imaging and physiology may be key to managing non-culprit lesions. Hosted on Acast. See acast.com/privacy for more information.
S1 · E8 · 5 Jul 2026 · 13 min
Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial: Original Research
In this episode of Editor's Choice, Dr Aaysha Cader speaks with Professor Huimin Chu about LAAC with AnchorMan versus Watchman 2.5 devices. They discuss how the 12-month results of the SAFE-PROTECT trial indicated the non-inferiority of the novel AnchorMan occluder for both primary and secondary endpoints: clinical success and LAA closure success at 1 year. This study found that the AnchorMan’s design, intended to improve sealing, resulted in significantly lower peridevice leak ≥3 mm compared to Watchman 2.5. Hosted on Acast. See acast.com/privacy for more information.
S1 · E7 · 17 Jun 2026 · 18 min
Door-to-unload time and mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock: Original Research
In this episode of Editor's Choice, Doctor Aaysha Cader speaks with Doctor Shin Nagai and Professor Toyoaki Murohara about the connection between door-to-unload time and mortality in STEMI-CS patients. They discuss how the J-PVAD registry data confirm that early unloading and prompt revascularisation are paramount; as high-volume centres achieve these targets more consistently, organised shock systems of care, such as hub-and-spoke models, appear invaluable. Hosted on Acast. See acast.com/privacy for more information.
S1 · E6 · 1 Jun 2026 · 16 min
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios: State-of-the-Art
In this episode of Editor's Choice, Doctor Aaysha Cader speaks with Professor Giuseppe Tarantini about the current state-of-the-art on TAVI and coronary interventions, recently published in EuroIntervention. Professor Tarantini shares insights on managing the complex interaction between CAD, PCI, and TAVI; the value of CT imaging and angiography in strategy planning; and how to optimise outcomes in different clinical scenarios. Hosted on Acast. See acast.com/privacy for more information.
S1 · E5 · 15 May 2026 · 15 min
Glucocorticoids to reduce PPI after TAVI: the GLUCO-TAVI randomised trial: Original Research
In this episode of Editor’s Choice, Dr Aaysha Cader speaks with Dr Juan Miguel Ruiz-Nodar about the results of the GLUCO-TAVI trial, recently published in EuroIntervention. They discuss the impact of glucocorticoid therapy on reducing permanent pacemaker implantation (PPI) following TAVI, highlighting a 50% relative risk reduction at one month. Dr Ruiz-Nodar also shares insights into the mechanisms behind these findings and outlines plans for a larger randomised trial to confirm the results and define optimal dosing and treatment duration. Hosted on Acast. See acast.com/privacy for more…
S1 · E4 · 6 May 2026 · 15 min
QFR versus FFR in the 2-year follow-up of FAVOR III Europe: Original Research
In this episode of Editor’s Choice, Dr Aaysha Cader speaks with Doctor Birgitte Andersen about the latest findings from the FAVOR III Europe trial, recently published in EuroIntervention. They discuss the 2-year follow-up comparing quantitative flow ratio (QFR) and fractional flow reserve (FFR), including the key outcome that QFR did not demonstrate non-inferiority at one year. Dr Andersen explores potential explanations, including concerns around reproducibility and early event rate differences, and highlights the need for further research to identify patient populations best suited for…
S1 · E3 · 27 Apr 2026 · 16 min
The ELASTA-T technique: Expert Review
In this episode of Editor’s Choice, Dr Aaysha Cader speaks with Professor Michael Joner about the ELASTA-T technique, presented in the Expert Review, “Electrosurgical Laceration and Stabilisation of Tricuspid Edge-to-Edge Repair: the ELASTA-T Technique,” recently published in EuroIntervention. Professor Joner explains the clinical rationale behind ELASTA-T and its potential role in the evolving treatment landscape for recurrent tricuspid valve regurgitation. He describes how the technique can facilitate and stabilise tricuspid edge-to-edge repair, before walking listeners through the key…
S1 · E2 · 13 Apr 2026 · 13 min
High ischaemic risk criteria in CCS patients undergoing PCI: Original Research
In this episode of Editor’s Choice, Professor Roxana Mehran discusses her original research article, “Prevalence and Prognostic Impact of High Ischaemic Risk Criteria in Chronic Coronary Syndrome Patients Undergoing PCI,” recently published in EuroIntervention. In conversation with Dr Aaysha Cader, Professor Mehran explores the background, methodology, and key findings from this study conducted in patients with chronic coronary syndrome (CCS) at Mount Sinai Hospital. She highlights the prevalence of high ischaemic risk features, their association with major adverse cardiac and…
S1 · E1 · 31 Mar 2026 · 17 min
Transcatheter Aortic Valve Thrombosis: State-of-the-Art
In the first episode of Editor’s Choice, podcast host Dr Aaysha Cader invite you to her conversation with Prof. Tobias Geisler and Dr. Mia Jacobsen about their review "State-of-the-Art: Transcatheter aortic valve thrombosis", recently published in EuroIntervention. Together, they break down why TAV thrombosis after TAVI/TAVR matters for clinicians today, clarify the key terminology used in the field, and review the latest recommendations for diagnosis, imaging strategies, and antithrombotic therapy. They also discuss the current evidence gaps and the future clinical trials needed to better…

About EuroIntervention | Editor's Choice

EuroIntervention | Editor's Choice is a English learning podcast from EuroIntervention. Melo plays each episode straight from the publisher's own feed — no ads added, no account needed — and remembers where you stopped, in this browser only.

Publisher: EuroIntervention
Language: English
Category: Learning
New episodes: Every two weeks
Typical length: 16 min
Latest episode: 15 Oct 2026
Feed: RSS — paste into any podcast app
Apple Podcasts: podcasts.apple.com/podcast/id1889537316
Rights: EuroIntervention

RSS feed Apple Podcasts

More English learning

Take it with you

The Melo app keeps playing with the screen off, works in the car and on your watch, wakes you to your station, and browses the whole catalogue offline. Free, no ads, no account.